文献速递前列腺癌

在评估真实世界前列腺癌主动监测结局的观察性研究中定义和测量依从性:一项系统综述

Defining and Measuring Adherence in Observational Studies Assessing Outcomes of Real-world Active Surveillance for Prostate Cancer: A Systematic Review.
PubMed 文献 · Eur Urol Oncol · 2019-07-06

该系统综述检索了截至2019年3月22日PubMed、Embase和CENTRAL的观察性研究,纳入45项评估前列腺癌主动监测结局的研究。11项研究未报告任何依从性数据,25项未明确测量依从性但提供相关数据,6项使用时间限定定义,3项使用二分定义,23项提供失访信息。作者认为多数研究未测量或报告依从性,临床实践和未来研究应追踪并报告依从性及相关因素。

要点

  • 45项真实世界主动监测观察性研究中,11项未报告任何依从性数据。
  • 25项未明确测量依从性但提供相关数据,仅6项使用时间限定定义。
  • 作者认为临床实践和未来研究应追踪并报告依从性及相关因素。

核心结论

  • 多数报告主动监测患者结局的研究未测量或报告依从性,报告时也常不具时间特异性。
  • 作者认为临床实践和未来研究应追踪并报告依从性及相关因素。

研究设计与样本

  • 系统综述,检索PubMed、Embase和CENTRAL中2019年3月22日前发表的评估前列腺癌主动监测患者结局的观察性研究。
  • 共纳入45项符合标准的研究,使用加强观察性流行病学研究报告声明清单评估研究质量。

主要发现

  • 45项研究中,11项未报告任何主动监测方案依从性数据。
  • 25项研究未明确测量依从性但提供了相关数据,如接受重复活检的患者数。
  • 6项研究使用时间限定定义报告依从性,3项研究使用二分定义。
  • 23项研究提供了失访患者的信息。

关键数值与推荐

  • 依从性定义若包含预设时间则视为时间限定,若评估依从性但未指定时间间隔则视为二分定义。

临床怎么用

  • 作者认为临床实践和未来研究应追踪并报告依从性及相关因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Evidence-based guidelines for active surveillance (AS), a treatment option for men with low-risk prostate cancer, recommend regular follow-up at periodic intervals to monitor disease progression. However, gaps in monitoring can lead to delayed detection of cancer progression, leading to a missed window of curability. OBJECTIVE: We aimed to identify the extent to which real-world observational studies reported adherence to monitoring protocols among prostate cancer patients on AS. When reported, we sought to characterize definitions of adherence. EVIDENCE ACQUISITION: We systematically reviewed observational studies assessing outcomes of prostate cancer patients on AS, published before March 22, 2019 in PubMed, Embase, and CENTRAL. Adherence definitions were considered time bound if they included prespecified time and binary if adherence was assessed but did not specify a time interval. We assessed study quality using the Strengthening the Reporting of Observational Studies in Epidemiology checklist. EVIDENCE SYNTHESIS: Forty-five studies met our inclusion criteria. Eleven studies did not report any data on adherence to AS protocols. Twenty-five studies did not explicitly measure adherence, but provided relevant data (eg, number of patients who received a repeat biopsy). Six studies reported adherence using a time-bound definition, while three studies used a binary definition. Twenty-three studies provided information on patients lost to follow-up. CONCLUSIONS: Most studies reporting outcomes of patients on AS did not measure or report adherence. When reported, adherence was often not time specific. As some AS patients will benefit from maintaining a window of curability, clinical practices and future studies should track and report adherence and associated factors. PATIENT SUMMARY: We reviewed real-world observational studies examining outcomes of prostate cancer patients on active surveillance. Most studies did not clearly define or report adherence to monitoring protocols, which is important to consider for appropriate disease management.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Kith G, Lisker S, Sarkar U, et al. Defining and Measuring Adherence in Observational Studies Assessing Outcomes of Real-world Active Surveillance for Prostate Cancer: A Systematic Review. Eur Urol Oncol. 2019. PMID: 31288992. doi:10.1016/j.euo.2019.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。